Domain-built, fully traceable, and engineered for the regulated workflows of HEOR and market access teams worldwide.
Trained and optimized for HEOR and market access — not a general LLM wrapper. Natively understands HEOR methodologies, NICE appraisal logic, and CEA model structures.
Every output includes source citations and evidence grounding. Outputs are auditable — essential for regulatory submissions and payer negotiations.
Proprietary framework flags outputs by evidence quality, novelty risk, and domain complexity — telling users exactly when to trust vs. verify output.
Natively processes HTA reports in French, German, Italian, Spanish, and English — summarizing in English. Covers NICE, G-BA, HAS, ICER, CADTH, AIFA, AEM, and more.
Landscape assessments in 48 hours vs. months. Objection handlers in minutes. Frees senior experts for high-value strategic work that requires human judgment.
SSO/Auth0, role-based access control, TLS 1.2 encryption, data encrypted at rest. Client data is never used for model retraining or secondary purposes.
How HEOR and market access teams put ValueGen.AI to work every day.
"Build a cost-effectiveness model for semaglutide vs. liraglutide in type 2 diabetes for a US payer in Excel."
"Estimate the budget impact of lecanemab for early Alzheimer's disease for a Medicare plan and create an online dashboard."
"What evidence gaps exist in HTA submissions for CAR-T therapies in DLBCL?"
"Summarize NICE's rationale for rejecting [Drug X] and propose counterarguments for re-submission."
"Create objection handler slides for payers skeptical of tirzepatide's long-term weight maintenance."
"Draft a 1-page payer briefing note justifying Zolgensma's upfront cost vs. lifetime savings."
Start with the core platform and add advanced modeling, dossier, and country-adaptation modules as needs scale.
| Capability | Standard | Premium Tier |
|---|---|---|
| Natural language query interface | ✓ | ✓ |
| Evidence synthesis & literature intelligence | ✓ | ✓ |
| HTA body insights (NICE, G-BA, ICER, CADTH, HAS, AIFA, AEM) | ✓ | ✓ |
| Conceptual model development & value framework design | ✓ | ✓ |
| Evidence gap identification & prioritization | ✓ | ✓ |
| Deep research agent with full citation traceability | ✓ | ✓ |
| Payer objection insights & value narrative drafts | ✓ | ✓ |
| Query reliability scoring & validation flags | ✓ | ✓ |
| Cost-effectiveness model build (Excel / R) | + | |
| Budget impact model (Excel) | + | |
| Online interactive model & dashboard | + | |
| HTA dossier drafting (NICE, G-BA, CADTH, ICER) | + | |
| Global value dossier generation | + | |
| Country model adaptation packages | + |
Enterprise licensing available · Volume tiers per user at scale · Annual subscription · Custom SOW
Book a guided walkthrough across HEOR and market access use cases — tailored to your portfolio and priority markets.
Request a Demo